Octapharma Plasma Inc – FDA 483, Mar 4, 2022
Octapharma Plasma Inc, a source plasma establishment in Knoxville, TN, was inspected by the FDA from February 23 to March 4, 2022. The inspection revealed significant deficiencies in the firm's adherence to its own written procedures for managing major deviations and corrective and preventive actions (CAPAs). Specifically, the firm failed to initiate CAPAs for several major deviations and did not close a substantial number of CAPAs within the required timeframe, indicating a systemic issue with quality system compliance.
ID · cfacf37b-618a-4bc6-a5a3-db72524622dd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.